{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:14:20Z","timestamp":1792167260307,"version":"4.4.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejphar.2019.02.022","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T23:18:06Z","timestamp":1550099886000},"page":"107-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives"],"prefix":"10.1016","volume":"852","author":[{"given":"Aniket V.","family":"Mali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash B.","family":"Padhye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrikant","family":"Anant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahabaleshwar V.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivajirao S.","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.02.022_bib1","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1017\/S0007114512004424","article-title":"Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women","volume":"109","author":"Aarestrup","year":"2013","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00404-011-2120-6","article-title":"Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20","volume":"285","author":"Abarzua","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejphar.2019.02.022_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/10408360701612942","article-title":"Lignans and human health","author":"Adlercreutz","year":"2007","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.ejphar.2019.02.022_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(82)91507-0","article-title":"Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer","volume":"320","author":"Adlercreutz","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.02.022_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0960-0760(94)00146-D","article-title":"Lignan and isoflavonoid conjugates in human urine","volume":"52","author":"Adlercreutz","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0960-0760(93)90022-O","article-title":"Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens","volume":"44","author":"Adlercreutz","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/jmf.2012.0159","article-title":"Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer","volume":"16","author":"Azrad","year":"2013","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ejphar.2019.02.022_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.taap.2016.10.021","article-title":"Enterolactone: a novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis","volume":"313","author":"Bigdeli","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.taap.2016.10.021","article-title":"Enterolactone: a novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis","volume":"313","author":"Bigdeli","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0959-8049(03)00576-8","article-title":"Serum enterolactone levels and the risk of breast cancer in women with palpable cysts","volume":"40","author":"Boccardo","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib11","first-page":"184","article-title":"Effects of components present in flaxseed on human colon adenocarcinoma Caco-2 cells: possible mechanisms of flaxseed on colon cancer development in animals","volume":"4","author":"Bommareddy","year":"2010","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.ejphar.2019.02.022_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jsbmb.2005.02.002","article-title":"Mammalian lignans and genistein decrease the activities of aromatase and 17\u03b2-hydroxysteroid dehydrogenase in MCF-7 cells","volume":"94","author":"Brooks","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib13","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2011.34.6478","article-title":"Serum enterolactone and prognosis of postmenopausal breast cancer","volume":"29","author":"Buck","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/bjc.2011.374","article-title":"Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer","volume":"105","author":"Buck","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3945\/ajcn.2009.28573","article-title":"Meta-analyses of lignans and enterolignans in relation to breast cancer risk","volume":"92","author":"Buck","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fnut.2018.00004","article-title":"The effect of flaxseed in breast cancer: a literature review","volume":"5","author":"Calado","year":"2018","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1024513815374","article-title":"Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro","volume":"80","author":"Chen","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2019.02.022_bib18","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1535-7163.MCT-07-0220","article-title":"Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway","volume":"6","author":"Chen","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.02.022_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3945\/jn.108.101832","article-title":"Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells","volume":"139","author":"Chen","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12906-016-1512-3","article-title":"Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines","volume":"17","author":"Chikara","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ejphar.2019.02.022_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/01635581.2017.1296169","article-title":"Enterolactone Induces G1-phase cell cycle arrest in nonsmall cell lung cancer cells by downregulating cyclins and cyclin-dependent kinases","volume":"69","author":"Chikara","year":"2017","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S0954422407249704","article-title":"Bioavailability of lignans in human subjects","volume":"19","author":"Clavel","year":"2006","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1574-6941.2005.00057.x","article-title":"Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside","volume":"55","author":"Clavel","year":"2006","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib24","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1021\/jf100471n","article-title":"Enterodiol and enterolactone modulate the immune response by acting on nuclear factor-\u03baB (NF-\u03baB) signaling","volume":"58","author":"Corsini","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2019.02.022_bib25","first-page":"815","article-title":"Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai","volume":"11","author":"Dai","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib26","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0959-8049(98)00223-8","article-title":"Regulation of c- fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells","volume":"34","author":"Dale","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib27","first-page":"2269","article-title":"Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo","volume":"25","author":"Danbara","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib28","first-page":"223","article-title":"Urinary phytoestrogens and postmenopausal breast cancer risk","volume":"10","author":"den Tonkelaar","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib29","first-page":"1","article-title":"Flaxseed lignans enhance the cytotoxicity of chemotherapeutic agents against breast cancer cell lines MDA-MB-231 and SKBR3","volume":"5581","author":"Di","year":"2018","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/ejcn.2017.42","article-title":"Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer","volume":"71","author":"Eriksen","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib31","series-title":"Cancer Today","author":"Ervik","year":"2016"},{"key":"10.1016\/j.ejphar.2019.02.022_bib32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1248\/bpb.31.1067","article-title":"Effects of metabolites of the lignans enterolactone and enterodiol on osteoblastic differentiation of MG-63 cells","volume":"31","author":"Feng","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2019.02.022_bib33","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jff.2017.06.038","article-title":"The Breast Cancer Resistance Protein (BCRP \/ ABCG2) influences the levels of enterolignans and their metabolites in plasma, milk and mammary gland","volume":"35","author":"Garc\u00eda-mateos","year":"2017","journal-title":"J. Funct. Foods J."},{"key":"10.1016\/j.ejphar.2019.02.022_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015","volume":"3","author":"Global Burden of Disease Cancer Collaboration","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-011-1881-8","article-title":"Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study","volume":"132","author":"Guglielmini","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2019.02.022_bib37","first-page":"13","article-title":"Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies","author":"He","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1017\/S0007114507700703","article-title":"Phyto-oestrogens and risk of prostate cancer in Scottish men","volume":"98","author":"Heald","year":"2007","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib39","first-page":"169","article-title":"Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the Cancer Prostate Sweden Study (Sweden)","volume":"17","author":"Hedelin","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejphar.2019.02.022_bib40","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.7314\/APJCP.2013.14.6.3987","article-title":"What is a cancer cell? Why does it metastasize?","volume":"14","author":"Hegde","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/pcan.2012.24","article-title":"Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations","volume":"15","author":"Ho","year":"2012","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ejphar.2019.02.022_bib42","first-page":"1","article-title":"Nutrition-derived bioactive metabolites produced by gut microbiota and their potential impact on human health","volume":"1","author":"H\u00f6gger","year":"2013","journal-title":"Nutr. Med."},{"key":"10.1016\/j.ejphar.2019.02.022_bib43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/aje\/154.5.434","article-title":"Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study","volume":"154","author":"Horn-Ross","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00394-002-0373-3","article-title":"An incident case-referent study on plasma enterolactone and breast cancer risk","volume":"41","author":"Hult\u00e9n","year":"2002","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib45","first-page":"37","article-title":"Enterolactone reduces telomerase activity and the level of its catalytic subunit in breast cancer cells","volume":"19","author":"Ilbeigi","year":"2017","journal-title":"Cell J."},{"key":"10.1016\/j.ejphar.2019.02.022_bib46","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(97)01339-1","article-title":"Case-control study of phyto-oestrogens and breast cancer","volume":"350","author":"Ingram","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.02.022_bib47","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.apjtb.2017.10.016","article-title":"Plant-derived anticancer agents: a green anticancer approach","volume":"7","author":"Iqbal","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ejphar.2019.02.022_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.abb.2004.12.015","article-title":"Uptake and metabolism of enterolactone and enterodiol by human colon epithelial cells","volume":"435","author":"Jansen","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2019.02.022_bib49","first-page":"153","article-title":"Plasma enterolactone and risk of colon and rectal cancer in a case\u2013cohort study of Danish men and women","volume":"21","author":"Johnsen","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejphar.2019.02.022_bib50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1078-0432.CCR-06-1651","article-title":"Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo","volume":"13","author":"Jungestr\u00f6m","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/153537020422900510","article-title":"Chemopreventive effects of hydroxymatairesinol on uterine carcinogenesis in Donryu rats","volume":"229","author":"Katsuda","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2019.02.022_bib52","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.biopha.2017.10.124","article-title":"Pharmacotherapeutic potential of phytochemicals: implications in cancer chemoprevention and future perspectives","volume":"97","author":"Kaur","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2019.02.022_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijc.11519","article-title":"Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study","volume":"108","author":"Kilkkinen","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib54","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1055-9965.EPI-05-0991","article-title":"Plasma enterolignans are associated with lower colorectal adenoma risk","volume":"15","author":"Kuijsten","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/jn\/135.4.795","article-title":"Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside","volume":"135","author":"Kuijsten","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib56","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/aje\/kwm349","article-title":"Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study","volume":"167","author":"Kuijsten","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib57","first-page":"1","article-title":"Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish diet, cancer and health cohort","author":"Kyr\u00f8","year":"2017","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib58","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jaoac\/89.4.1174","article-title":"Assessing exposure to lignans and their metabolites in humans","volume":"89","author":"Lampe","year":"2006","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.ejphar.2019.02.022_bib59","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1080\/10408398.2013.789823","article-title":"Bioactivation of phytoestrogens: intestinal bacteria and health","volume":"56","author":"Landete","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib60","article-title":"Effect of mammalian lignans on the growth of prostate cancer cell lines","author":"Lin","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/0008-5472.CAN-10-2289","article-title":"Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer","volume":"71","author":"Lindahl","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib62","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ijc.20119","article-title":"Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study","volume":"110","author":"Linseisen","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13048-017-0346-z","article-title":"Enterolactone has stronger effects than enterodiol on ovarian cancer","volume":"10","author":"Liu","year":"2017","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib64","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jn\/136.4.906","article-title":"Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats","volume":"136","author":"Liu","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/carcin\/bgr256","article-title":"Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer","volume":"33","author":"Mabrok","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2019.02.022_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2017.10.020","article-title":"A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum)","author":"Majdalawieh","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib67","first-page":"905","article-title":"Enterolactone suppresses proliferation, migration and metastasis of MDA-MB-231 breast cancer cells through inhibition of uPA induced plasmin activation and MMPs-mediated ECM remodeling","volume":"18","author":"Mali","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/0019-509X.98948","article-title":"In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines","volume":"49","author":"Mali","year":"2012","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20892\/j.issn.2095-3941.2018.0012","article-title":"Enterolactone modulates the ERK\/NF-\u03baB\/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB- 231 to revert the TGF-\u03b2-induced epithelial\u2013mesenchymal transition","volume":"15","author":"Mali","year":"2018","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ejphar.2019.02.022_bib70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrclinonc.2016.24","article-title":"Diet, nutrition, and cancer: past, present and future","volume":"13","author":"Mayne","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/mnfr.200700052","article-title":"Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell linein vitro","volume":"52","author":"McCann","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib72","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mnfr.201200362","article-title":"Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis","volume":"57","author":"Mccann","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib73","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/nu6114839","article-title":"The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA licencing genes, Mi-R106b cluster expression, And PTEN dosage","volume":"6","author":"McCann","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2019.02.022_bib74","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/jn\/131.10.3036","article-title":"The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women","volume":"132","author":"McCann","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib75","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.20262","article-title":"Dietary lignan intakes and risk of pre- and postmenopausal breast cancer","volume":"111","author":"McCann","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib76","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1039\/C7FO00684E","article-title":"Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets","volume":"8","author":"Miles","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2019.02.022_bib77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/01635580701308133","article-title":"Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats","volume":"58","author":"Miura","year":"2007","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/np4004905","article-title":"Permeability and conjugative metabolism of flaxseed lignans by caco-2 human intestinal cells","volume":"77","author":"Mukker","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2019.02.022_bib79","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10549-011-1397-2","article-title":"Prediagnostic plasma enterolactone levels and mortality among women with breast cancer","volume":"128","author":"Olsen","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2019.02.022_bib80","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1158\/1055-9965.2084.13.12","article-title":"plasma enterolactone and breast cancer incidence by estrogen receptor status plasma enterolactone and breast cancer incidence by estrogen receptor status","volume":"13","author":"Olsen","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib81","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/jn\/135.5.1056","article-title":"Dietary Sesamin Is converted to enterolactone in humans","volume":"135","author":"Pen","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib82","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1753-4887.2010.00319.x","article-title":"Dietary lignans: physiology and potential for cardiovascular disease risk reduction","volume":"68","author":"Peterson","year":"2010","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib83","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1021\/jf102006w","article-title":"Estrogenic activities of sesame lignans and their metabolites on human breast cancer cells","volume":"59","author":"Pianjing","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2019.02.022_bib84","first-page":"339","article-title":"Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland","volume":"10","author":"Pietinen","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.cej.0000197449.56862.75","article-title":"Plasma enterolactone and genistein and the risk of premenopausal breast cancer","volume":"15","author":"Piller","year":"2006","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib86","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.21464","article-title":"Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice","volume":"118","author":"Power","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib87","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bone.2005.12.015","article-title":"Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model","volume":"39","author":"Power","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ejphar.2019.02.022_bib88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40880-017-0206-7","article-title":"Cancer metastasis: issues and challenges","volume":"36","author":"Qian","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib89","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/jn\/135.3.598","article-title":"Lignans are involved in the antitumor activity of wheat bran in colon cancer SW480 cells","volume":"135","author":"Qu","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00253-011-3338-8","article-title":"Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside","volume":"92","author":"Roncaglia","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib91","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ijc.25052","article-title":"Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo","volume":"127","author":"Saarinen","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib92","first-page":"869","article-title":"Enterolactone inhibits the growth of 7,12-Dimethylbenz(a) anthracene-induced mammary carcinomas in the rat","volume":"1","author":"Saarinen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.02.022_bib93","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.294.12.1493","article-title":"Dietary phytoestrogens and lung cancer risk","volume":"294","author":"Schabath","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2019.02.022_bib94","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/nu8100616","article-title":"Effects of phytoestrogen extracts isolated from elder flower on hormone production and receptor expression of trophoblast tumor cells JEG-3 and BeWo, as well as MCF7 breast cancer cells","volume":"8","author":"Schr\u00f6der","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2019.02.022_bib95","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ijc.28729","article-title":"Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis","volume":"135","author":"Seibold","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib96","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1039\/C3FO60402K","article-title":"Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans","volume":"5","author":"Setchell","year":"2014","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2019.02.022_bib97","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1158\/1055-9965.EPI-08-0393","article-title":"Enterolactone is differently associated with estrogen receptor B \u2013 negative and \u2013 positive breast cancer in a Swedish Nested Case-Control Study","volume":"17","author":"Sonestedt","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ijc.10313","article-title":"Circulating enterolactone and prostate cancer risk: a nordic nested case-control study","volume":"99","author":"Stattin","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib99","first-page":"1095","article-title":"Prospective study of plasma enterolactone and prostate cancer risk (Sweden)","volume":"15","author":"Stattin","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejphar.2019.02.022_bib100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgv166","article-title":"Cancer prevention as part of precision medicine: \u201cplenty to be done.\u201d","volume":"37","author":"Stewart","year":"2016","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2019.02.022_bib101","first-page":"1405","article-title":"Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells","volume":"18","author":"Sung","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib102","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib103","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/bdd.1862","article-title":"Pharmacokinetics and safety of the sesame lignans, sesamin and episesamin, in healthy subjects","volume":"34","author":"Tomimori","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejphar.2019.02.022_bib104","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djk096","article-title":"Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status","volume":"99","author":"Touillaud","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2019.02.022_bib105","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1158\/1055-9965.EPI-06-0543","article-title":"No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French Cohort Study","volume":"15","author":"Touillaud","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib106","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.bjc.6605073","article-title":"Plasma phyto-oestrogens and prostate cancer in the European prospective investigation into cancer and nutrition","volume":"100","author":"Travis","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib107","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2006.06.0244","article-title":"Plasma phytoestrogens and subsequent breast cancer risk","volume":"25","author":"Verheus","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib108","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","article-title":"Global cancer patterns: causes and prevention","volume":"383","author":"Vineis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.02.022_bib109","first-page":"1","article-title":"Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men","author":"Wallstr\u00f6m","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-2952(98)00141-5","article-title":"Induction of NADPH: quinone reductase by dietary phytoestrogens in colonic Colo205 cells","volume":"56","author":"Wang","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.022_bib111","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3945\/ajcn.2009.28282","article-title":"Breast, colorectal, and prostate cancer risk in the European prospective investigation into cancer and nutrition \u2013 Norfolk in relation to phytoestrogen intake derived from an improved database 1 \u2013 4","volume":"91","author":"Ward","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.022_bib112","first-page":"1","article-title":"Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European prospective into cancer-Norfolk cohort study","volume":"10","author":"Ward","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib113","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ctrv.2011.03.001","article-title":"Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives","volume":"38","author":"Weng","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ejphar.2019.02.022_bib114","article-title":"Food, nutrition, physical activity, and the prevention of cancer: a global perspective","author":"World Cancer Research Fund","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.02.022_bib115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10549-013-2586-y","article-title":"Plasma enterolactone and breast cancer risk in the Nurses' Health Study II","volume":"139","author":"Xie","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2019.02.022_bib116","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/01635581.2015.1082113","article-title":"Inhibitory effects of enterolactone on growth and metastasis in human breast cancer","volume":"67","author":"Xiong","year":"2015","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib117","doi-asserted-by":"crossref","first-page":"e31020","DOI":"10.1371\/journal.pone.0031020","article-title":"Genetic susceptibility on cagA-interacting molecules and gene-environment interaction with phytoestrogens: a putative risk factor for gastric cancer","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.02.022_bib118","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/ijc.26157","article-title":"Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status","volume":"130","author":"Zaineddin","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.bjc.6601893","article-title":"Circulating enterolactone and risk of breast cancer: a prospective study in New York","volume":"91","author":"Zeleniuch-Jacquotte","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2019.02.022_bib120","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/ijc.22140","article-title":"Circulating enterolactone and risk of endometrial cancer","volume":"119","author":"Zeleniuch-Jacquotte","year":"2006","journal-title":"Int. J. Cancer"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:27:08Z","timestamp":1757975228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919301116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":120,"alternative-id":["S0014299919301116"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.022","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}